Citizens Business Bank’s Meridian Bioscience Inc VIVO Stock Holding History

Citizens Business Bank’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$263K	–	256
2021 Q1	$263K	Hold	10,000	–	–	0.04%	225
2020 Q4	$187K	Hold	10,000	–	–	0.03%	231
2020 Q3	$170K	Hold	10,000	–	–	0.03%	220
2020 Q2	$233K	Hold	10,000	–	–	0.04%	217
2020 Q1	$84K	Hold	10,000	–	–	0.02%	227
2019 Q4	$98K	Hold	10,000	–	–	0.02%	235
2019 Q3	$95K	Hold	10,000	–	–	0.02%	243
2019 Q2	$119K	Hold	10,000	–	–	0.02%	245
2019 Q1	$176K	Hold	10,000	–	–	0.03%	238
2018 Q4	$174K	Hold	10,000	–	–	0.03%	248
2018 Q3	$149K	Hold	10,000	–	–	0.03%	267
2018 Q2	$159K	Hold	10,000	–	–	0.03%	260
2018 Q1	$142K	Hold	10,000	–	–	0.02%	260
2017 Q4	$140K	Hold	10,000	–	–	0.02%	274
2017 Q3	$143K	Hold	10,000	–	–	0.02%	275
2017 Q2	$158K	Hold	10,000	–	–	0.03%	276
2017 Q1	$138K	Buy	+10,000	New	+$140K	0.02%	268

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citizens Business Bank's VIVO Position: Q2 2021 in Review

Citizens Business Bank sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 10,000 shares — an estimated $263K sold.

Citizens Business Bank first reported a position in VIVO in Q1 2017 and held it in 17 quarters. The position peaked at $263K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

Citizens Business Bank reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
Citizens Business Bank sold 10,000 Meridian Bioscience Inc shares in Q2 2021, an estimated $263K.
Citizens Business Bank first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 17 quarters.
Citizens Business Bank's Meridian Bioscience Inc position peaked at $263K in Q1 2021.
189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Citizens Business Bank's 13F filing for Q2 2021, filed 18 Nov 2022.